Targeted optogenetic inhibition with multi-channel recordings
Jonathan Green et al. with Christopher Harvey’s lab at Harvard Medical School used NeuroNexus optoelectrodes A1x32-Poly2-5mm-50s-177-OA32LP in transgenic mice to test for effects of their inhibitory opsin at the population level.
Related Topics
Exploring Auditory Neuroscience at the Biennial Woods Hole Summer School: A Deep Dive into the Biology of the Inner Ear
Every two years, some of the brightest m…
Read publication
7 Years Later: Revolutionizing Neural Research with SiC
NeuroNexus is committed to continuous im…
Read publication
A brief history of electrode technology
Our history of microelectrode technology…
Read publication
